ATX-304

N/A

Report date: 2026/04/08 15:32:28
NME

Base Information

Drug NameATX-304
Drug Alias NameO-304ATX-304O-304X
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activatorsProprotein convertase subtilisin kexin type 9 inhibitors
TargetsProtein kinase AMP-activated non-catalytic subunit beta 1Proprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsMitochondrial DiseasesDiabetes Mellitus, Type 2Peripheral Arterial Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBetagenon Ab
China Registration ClassN/A

Develop Information

Active CompaniesCambrian Biopharma IncAmplifier Therapeutics ABMcg Technology Group Ltd
Inactive CompaniesN/A
Active IndicationsMitochondrial DiseasesDiabetes Mellitus, Type 2Peripheral Arterial Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A